FAM135B suppresses glioblastoma angiogenesis via stabilizing the IKK complex and inactivating the NF-κB/IL-6 signaling pathway.
Overview
- Neurosurgery Center, Department of Neuro-oncological Surgery, The National Key Clinical Specialty, Engineering Research Center of Diagnostic and Therapeutic Technology and Devices for Cerebrovascular Diseases, Ministry of Education, Guangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, Zhujiang Hospital Institute for Brain Science and Intelligence, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282 China
- Division of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong Province China
- Department of Pathology, Shunde Hospital, Southern Medical University, (The First People’s Hospital of Shunde), Foshan, China
- Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
- Department of Radiology, Nanfang Hospital, Southern Medical University, Guangzhou, China
- Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China
- Department of Radiology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
- Department of Neurosurgery, School of Medicine, The Sixth Affiliated Hospital of South China University of Technology (Nanhai District People’s Hospital of Foshan), Foshan, 528200 China
Abstract
The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE53733, at NCBI GEO; found in the text, “FAM135B suppresses angiogenesis by inhibiting…”
Data availability statement
The paper has a data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:
- no repository, dataset or request procedure was recognized in it
Read it in the paper: doi.org/10.1186/s12967-026-08397-3.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 14 authors, 5 keywords, 16 MeSH terms, 2 funders, 26 references.
Cite
This paper
Wang, C., Zhang, F., Hao, L., Zhang, Y., Feng, C., Weng, N., Hu, P., Lin, W., Chen, T., Wang, T., Zhang, Y., Ke, Y., Zhao, L., & Chen, Z. (2026). FAM135B suppresses glioblastoma angiogenesis via stabilizing the IKK complex and inactivating the NF-κB/
BibTeX
@article{wang2026fam135b
author = {Wang, Chuangyuan and Zhang, Fabing and Hao, Liwei and Zhang, Yujie and Feng, Chenya and Weng, Nuozhou and Hu, Peiqian and Lin, Wanmei and Chen, Taoliang and Wang, Tianwei and Zhang, Yinian and Ke, Yiquan and Zhao, Liang and Chen, Zetao},
title = {{FAM135B suppresses glioblastoma angiogenesis via stabilizing the IKK complex and inactivating the NF-κB/
journal = {Journal of translational medicine},
year = {2026},
month = jun,
volume = {24},
number = {1},
pages = {1046},
publisher = {BMC},
issn = {1479-5876},
doi = {10.1186/
url = {https://
pmid = {42260484},
pmcid = {PMC13471341}
}
RIS
TY - JOUR
AU - Wang, Chuangyuan
AU - Zhang, Fabing
AU - Hao, Liwei
AU - Zhang, Yujie
AU - Feng, Chenya
AU - Weng, Nuozhou
AU - Hu, Peiqian
AU - Lin, Wanmei
AU - Chen, Taoliang
AU - Wang, Tianwei
AU - Zhang, Yinian
AU - Ke, Yiquan
AU - Zhao, Liang
AU - Chen, Zetao
TI - FAM135B suppresses glioblastoma angiogenesis via stabilizing the IKK complex and inactivating the NF-κB/
T2 - Journal of translational medicine
J2 - J Transl Med
PY - 2026
DA - 2026/
VL - 24
IS - 1
SP - 1046
SN - 1479-5876
PB - BMC
DO - 10.1186/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1186/
"type": "article-journal",
"title": "FAM135B suppresses glioblastoma angiogenesis via stabilizing the IKK complex and inactivating the NF-κB/
"container-title": "Journal of translational medicine",
"author": [
{
"family": "Wang",
"given": "Chuangyuan"
},
{
"family": "Zhang",
"given": "Fabing"
},
{
"family": "Hao",
"given": "Liwei"
},
{
"family": "Zhang",
"given": "Yujie"
},
{
"family": "Feng",
"given": "Chenya"
},
{
"family": "Weng",
"given": "Nuozhou"
},
{
"family": "Hu",
"given": "Peiqian"
},
{
"family": "Lin",
"given": "Wanmei"
},
{
"family": "Chen",
"given": "Taoliang"
},
{
"family": "Wang",
"given": "Tianwei"
},
{
"family": "Zhang",
"given": "Yinian"
},
{
"family": "Ke",
"given": "Yiquan"
},
{
"family": "Zhao",
"given": "Liang"
},
{
"family": "Chen",
"given": "Zetao"
}
],
"container-title-short":
"volume": "24",
"issue": "1",
"page": "1046",
"DOI": "10.1186/
"PMID": "42260484",
"PMCID": "PMC13471341",
"ISSN": "1479-5876",
"publisher": "BMC",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
8
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1038/s41698-024-00566-1
- ELAVL2 loss promotes aggressive mesenchymal transition in glioblastoma.Journal: NPJ precision oncologyIn common: NCBI GEO GSE53733, other condition, 2 references
- [2] doi:10.1111/cas.70218
- COL6A2: A Key Survival-Related Gene and Restricting Antitumor Immunity in Glioblastoma.Journal: Cancer scienceIn common: NCBI GEO GSE53733, other condition, mouse, cellular / molecular
- [3] doi:10.3390/biology15080633
- Development and Validation of a Toxoplasma Infection-Associated Risk Model for Prognostic Stratification and Treatment Guidance in Glioma.Journal: BiologyIn common: other condition, 4 references
- [4] doi:10.1038/s41423-025-01360-0
- C/
EBPβ-induced alternative splicing of RCAN1 generates a potent TCR-T target in mesenchymal glioblastoma. Journal: Cellular & molecular immunologyIn common: other condition, mouse, cellular / molecular, 4 references - [5] doi:10.1186/s40478-023-01613-x
- Decoding key cell sub-populations and molecular alterations in glioblastoma at recurrence by single-cell analysis.Journal: Acta neuropathologica communicationsIn common: other condition, cellular / molecular, 4 references
- [6] doi:10.1007/s10238-026-02097-4
- MEG3 in glioma stem cells promotes glioblastoma angiogenesis through FUBP3-mediated VGF expression.Journal: Clinical and experimental medicineIn common: other condition, mouse, cellular / molecular, 3 references
- [7] doi:10.3390/biomedicines13112640 [code]
- A Prognostic Neuromodulation-Related Gene Signature Identifies Immunomodulation and Tumour-Associated Hallmarks in Glioblastoma.Journal: BiomedicinesIn common: other condition, 4 references
- [8] doi:10.1038/s41467-025-58366-5 [code]
- Combined targeting of glioblastoma stem cells of different cellular states disrupts malignant progression.Journal: Nature communicationsIn common: other condition, mouse, cellular / molecular, 3 references
- [9] doi:10.3389/fgene.2024.1356611 [code]
- Cellular diversity through space and time: adding new dimensions to GBM therapeutic development.Journal: Frontiers in geneticsIn common: other condition, cellular / molecular, 3 references
- [10] doi:10.1038/s41467-025-59156-9 [code]
- Genomic landscape of diffuse glioma revealed by whole genome sequencing.Journal: Nature communicationsIn common: other condition, cellular / molecular, 3 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
